GIORDANO, Paola
 Distribuzione geografica
Continente #
NA - Nord America 19.198
AS - Asia 8.630
EU - Europa 8.372
SA - Sud America 2.558
AF - Africa 394
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 7
Totale 39.184
Nazione #
US - Stati Uniti d'America 18.891
SG - Singapore 3.727
BR - Brasile 2.057
CN - Cina 1.856
DE - Germania 1.613
IT - Italia 1.604
FR - Francia 1.240
HK - Hong Kong 1.095
SE - Svezia 1.004
RU - Federazione Russa 878
VN - Vietnam 546
UA - Ucraina 539
FI - Finlandia 525
GB - Regno Unito 503
IN - India 288
BD - Bangladesh 181
AR - Argentina 163
CA - Canada 136
IQ - Iraq 124
TR - Turchia 101
ID - Indonesia 98
CI - Costa d'Avorio 96
ZA - Sudafrica 94
MX - Messico 91
EC - Ecuador 86
PK - Pakistan 84
IE - Irlanda 81
CO - Colombia 71
NL - Olanda 69
VE - Venezuela 64
UZ - Uzbekistan 60
PL - Polonia 52
BE - Belgio 50
JP - Giappone 50
SA - Arabia Saudita 49
KR - Corea 46
MA - Marocco 45
PY - Paraguay 44
ES - Italia 42
AT - Austria 40
PH - Filippine 40
CL - Cile 33
KE - Kenya 31
MY - Malesia 29
AE - Emirati Arabi Uniti 27
TN - Tunisia 27
IL - Israele 23
JO - Giordania 22
EG - Egitto 21
LT - Lituania 21
AU - Australia 20
AZ - Azerbaigian 17
CZ - Repubblica Ceca 17
KZ - Kazakistan 17
PE - Perù 17
IR - Iran 16
OM - Oman 16
LB - Libano 15
DZ - Algeria 14
PS - Palestinian Territory 13
TH - Thailandia 13
DO - Repubblica Dominicana 12
NP - Nepal 12
BO - Bolivia 11
CR - Costa Rica 11
JM - Giamaica 11
RO - Romania 11
CH - Svizzera 10
GE - Georgia 10
PA - Panama 10
PT - Portogallo 10
UY - Uruguay 10
ET - Etiopia 9
AO - Angola 8
GR - Grecia 8
HN - Honduras 8
RS - Serbia 8
BG - Bulgaria 7
BH - Bahrain 7
KW - Kuwait 7
KG - Kirghizistan 6
NG - Nigeria 6
SK - Slovacchia (Repubblica Slovacca) 6
SN - Senegal 6
TT - Trinidad e Tobago 6
LY - Libia 5
NZ - Nuova Zelanda 5
SY - Repubblica araba siriana 5
AL - Albania 4
BT - Bhutan 4
BY - Bielorussia 4
GT - Guatemala 4
HR - Croazia 4
HU - Ungheria 4
KH - Cambogia 4
NI - Nicaragua 4
TW - Taiwan 4
AM - Armenia 3
BA - Bosnia-Erzegovina 3
BB - Barbados 3
Totale 39.102
Città #
Singapore 1.883
Fairfield 1.754
Ashburn 1.677
Woodbridge 1.526
Chandler 1.479
Jacksonville 1.269
San Jose 1.109
Hong Kong 1.088
Houston 948
Cambridge 797
Nyköping 757
Seattle 697
Wilmington 599
Ann Arbor 565
Beijing 459
Lawrence 392
Roxbury 390
Nanjing 362
Lauterbourg 358
Bari 354
New York 312
Des Moines 247
Dallas 239
Los Angeles 236
Boardman 192
Helsinki 191
Ho Chi Minh City 179
Princeton 159
São Paulo 159
Inglewood 136
Santa Clara 133
Hanoi 125
Buffalo 122
Munich 117
Council Bluffs 111
Brooklyn 108
San Diego 105
Milan 98
Abidjan 96
Chicago 94
Nanchang 88
Jiaxing 85
Shenyang 80
Hebei 79
Rome 78
Dublin 74
London 74
Rio de Janeiro 67
Dearborn 61
Paris 57
Frankfurt am Main 56
Moscow 54
Baghdad 51
Brussels 49
Tashkent 49
Belo Horizonte 47
Johannesburg 43
Orem 43
Tianjin 43
Tokyo 43
Warsaw 41
Montreal 40
Changsha 39
Redwood City 39
Chennai 37
Nuremberg 37
Atlanta 36
Brasília 36
Jakarta 36
Dhaka 34
Romola 34
Salt Lake City 34
Porto Alegre 32
Quito 32
San Francisco 32
Guangzhou 31
Phoenix 31
Pune 31
Toronto 30
Curitiba 29
Denver 28
Mexico City 27
Nairobi 27
Shanghai 26
Amsterdam 24
Boston 24
Campinas 24
Falkenstein 23
Lahore 23
Modugno 23
The Dalles 23
Ankara 22
Guayaquil 22
Manchester 22
Mumbai 22
Norwalk 22
Padova 22
Bologna 21
Caracas 21
Columbus 21
Totale 24.001
Nome #
Correzione dell'ipofibrinogenemia acquisita con concentrato di fibrinogeno in bambini affetti da LLA in trattamento con Asparaginasi. L'esperienza di due centri AIEOP 486
Serum Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Potential Diagnostic Biomarkers in Autism Spectrum Disorders: A Preliminary Study 273
Endothelial and Metabolic Function Interactions in Overweight/Obese Children. 259
Association between miRNAs expression and cognitive performances of Pediatric Multiple Sclerosis patients: A pilot study 243
Combined microRNA and mRNA expression analysis in pediatric multiple sclerosis: an integrated approach to uncover novel pathogenic mechanisms of the disease. 233
A Narrative Approach to Describe QoL in Children With Chronic ITP 190
Cognitive, emotional, and behavioral profile in children and adolescents with chronic pain associated with rheumatic diseases: A case-control study 183
Consensus statements on vaccination in patients with haemophilia-Results from the Italian haemophilia and vaccinations (HEVA) project 180
Association of congenital afibrinogenemia and k-dependent protein C deficiency - a case report 176
Authors' Reply to "CD10 in the Cytological Diagnosis of Endobronchial Endometriosis" 174
Can Anti-Thyroid Antibodies Influence the Outcome of Primary Chronic Immune Thrombocytopenia in Children? 173
How Physical Activity across the Lifespan Can Reduce the Impact of Bone Ageing: A Literature Review. 173
Non-alcoholic fatty liver disease is associated with early left ventricular dysfunction in childhood acute lymphoblastic leukaemia survivors. 173
Using pharmacokinetics for tailoring prophylaxis in people with hemophilia switching between clotting factor products: A scoping review 166
Serum D vitamin levels in children with immune thrombocytopenia 166
Lupus anticoagulant, anticardiolipin antibodies and hepatitis C virus infection in thalassaemia 165
APC Resistance in thalassemic patients and under-lying cause of thrombosis 165
Vascular Function and Myocardial Performance Indices in Children Born Small for Gestational Age. 163
Analysis of Circulating Mediators of Bone Remodeling in Prader-Willi Syndrome 162
Idiopathic neutropenia of infancy: Data from the Italian Neutropenia Registry 160
Thromboembolic risk in children with nephrotic syndrome 159
Metabolic syndrome in childhood leukemia survivors: a meta-analysis 155
A polycentric, randomized, parallel-group, study on Lertal®, a multicomponent nutraceutical, as preventive treatment in children with allergic rhinoconjunctivitis: phase II 155
Alagille syndrome: A novel mutation in JAG1 gene 155
A volleyball player with bilateral knee osteochondritis dissecant treated with extracorporeal shock wave therapy 154
Carotenoids and Cardiovascular Risk 154
Uric acid: from a biological advantage to a potential danger. A focus on cardiovascular effects 154
Vaccine administration and the development of immune thrombocytopenic purpura in children 153
Porpora trombocitopenica idiopatica (immune) (PTI) acuta in età pediatrica.Linee guida AIEOP per la diagnosi ed il trattamento 153
Cardiovascular dysfunction and vitamin D status in childhood acute lymphoblastic leukemia survivors 151
Lupus anticoagulant, anticardiolipin antibodies and hepatitis C virus infection in thalassaemia 150
Von Willebrand factor and factor XIII in children with Henoch-Schonlein purpura 150
B-cell hyperfunction in children with immune thrombocytopenic purpura persists after splenectomy 150
Pain assessment and management in haemophilia: A survey among Italian patients and specialist physicians 150
The role of endothelial dysfunction and oxidative stress in cerebrovascular diseases 149
Alterazioni coagulative e fibrinolitiche nel neonato pretermine affetto da: IRDS, asfissia alla nascita, sepsi 147
APC resistance in thalassemic patients:an under-lying cause of thrombosis 147
A practical approach to the use of low molecular weight heparins in VTE treatment and prophylaxis in children and newborns. 146
Uniparental disomy and pretreatment IGF-1 may predict elevated IGF-1 levels in Prader-Willi patients on GH treatment 146
Coagulation inhibitors (protein C and antithrombin III) in the preterm infant during the first month of life 145
New data from the Italian National Register of Congenital Coagulopathies, 2016 Annual Survey 144
Creazione del network italiano Asplenia per la gestione coordinata a livello nazionale dei pazienti asplenici: il ruolo dell'AIEOP e di altre società scientifiche 143
Endothelial dysfunction and cardiovascular risk factors in childhood acute lymphoblastic leukemia survivors Autori 142
DETERMINATION OF von WILLEBRAND FACTOR AND FACTOR XIII IN CHILDREN WITH SCHONLEIN HENOCH SYNDROME 141
Issues in pediatric haemophilia care 141
Human Fibrinogen Concentrate and Fresh Frozen Plasma in the Management of Severe Acquired Hypofibrinogenemia in Children with Acute Lymphoblastic Leukemia: Results of a Retrospective Survey 140
Thrombin generation in children with acute lymphoblastic leukemia (ALL): effects of ALL immunophenotypic subgroup on inherited thrombotic risk factors 139
Are all cases of paediatric essential thrombocythaemia really myeloproliferative neoplasms? Analysis of a large cohort 139
Covid-19 and children with immune thrombocytopenia: Emerging issues 139
Alterazioni delle cellule B della memoria nella piastrinopenia idiopatica 138
Effect of eradication of Helicobacter pylori in children with chronic immune thrombocytopenia: a prospective, controlled, multicenter study. 138
Neonatal bacterial meningitis: a systematic review of European available data 138
Afibrinogenemia congenita associata a deficit di PC K-dipendente 137
Risk factors for subclinical atherosclerosis in diabetic and obese children 136
Hereditary hemorrhagic telangiectasia: arteriovenous malformations in children. 135
Bodyweight-adjusted rivaroxaban for children with venous thromboembolism (EINSTEIN-Jr): results from three multicentre, single-arm, phase 2 studies 134
Afibrinogenemia congenita associata a deficit di PC K-dipendente 133
Validation of the ISTH/SSC bleeding assessment tool for inherited platelet disorders: a communication from the Platelet Physiology SSC 133
Metabolic, inflammatory, endothelial and haemostatic markers in a group of Italian obese children and adolescents 132
Mechanisms of enhanced osteoclastogenesis in Alkaptonuria 132
Analisi di Parametri di Coagulazione e Fibrinolisi in Bambini ed Adolescenti Obesi 131
Hepatic angiodynamic profile in paediatric patients with hereditary haemorrhagic telangiectasia type 1 and type 2 131
Thrombin generation in children with acute lymphoblastic leukemia: effect of leukemia immunophenotypic subgroups 131
APC resistance in thalassemic patients 130
Impact of sleep respiratory disorders on endothelial function in children. 129
Iodine absorption in celiac children: A longitudinal pilot study 129
K-dependent coagulant and anticoagulant factors deficiency in late haemorrhagic disease of the newborn 129
Thrombin activation in thalassemia major: effect of iron chelators and splenectomy 126
ANKRD26-related thrombocytopenia and myeloid malignancies. 126
Anomalie cellulari e plasmatiche della coagulazione e della fibrinolisi dei linfomi ed effetto della terapia 126
Sport and Children with Immune Thrombocytopenia: Never Give Up 126
Chronic immune thrombocytopenia in childhood 125
Coagulation and fibrinolytic systems in the ill preterm newborn 124
Thromboembolic risk in children with nephrotic syndrome 124
Present and Future of Pediatric Hemophilia Treatment 124
Analysis of coagulation and fibrinolysis parameters in obese children and adolescents 124
Basi genetiche della trombosi in età neonatale (analisi della prevalenza di 4 fattori di rischio nella popolazione italiana) 124
Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial 124
Thromboembolic risk in children with nephrotic syndrom. 123
Long-term follow-up analysis after rituximab therapy in children with refractory symptomatic ITP: identification of factors predictive of a sustained response 123
Clinical Data of Neonatal Systemic Thrombosis 123
Rituximab unveils hypogammaglobulinemia and immunodeficiency in children with autoimmune cytopenia 123
Preventing and Treating Colic 123
Autoimmune haematological disorders in two Italian children with Kabuki Syndrome 122
ITP-QoL Questionnaire for Children with Immune Thrombocytopenia: Italian Version validation's 121
Acute childhood idiopathic thrombocytopenic purpura: AIEOP consensus guidelines for diagnosis and treatment 121
ROLE OF ANTITHYROID AUTOIMMUNITY AS A PREDICTIVE BIOMARKER OF CHRONIC IMMUNE THROMBOCYTOPENIA 121
Organizing national responses for rare blood disorders: the Italian experience with sickle cell disease in childhood. 120
Analisi di parametri di coagulazione e fibrinolisi in bambini e adolescenti obesi 120
Catheter-related infections in pediatric patients with cancer. 119
Resistance to activated protein C in thalassaemic patients: an underlying cause of thrombosis 119
Contemporary deficiency of vitamin K-dependents procoagulants and anticoagulants (PC) in late hemorrhagic disease of newborn 119
Perceived well-being and mental health in haemophilia 119
Echovirus 11 lineage I and other enteroviruses in hospitalized children with acute respiratory infection in Southern Italy, 2022-2023 118
Rituximab (anti-CD20 monoclonal antibody) in children with chronic refractory symptomatic immune thrombocytopenic purpura: efficacy and safety of treatment 118
Coagulation inhibitors (PC and ATIII) in preterm infants during the first month of life 117
Guidelines for the use of long-term central venous catheter in children with hemato-oncological disorders. On behalf of supportive therapy working group of Italian Association of Pediatric Hematology and Oncology (AIEOP) 117
Cellular and plasmatic anomalies of the coagulation system and fibrinolysis in children with lymphomas and influence of cytostatic treatment 117
Therapeutic management and costs of severe haemophilia A patients with inhibitors in Italy 117
Protein C deficiency in two children with cerebral thrombosis 117
Totale 14.760
Categoria #
all - tutte 166.481
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 166.481


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021375 0 0 0 0 0 0 0 0 0 0 197 178
2021/20222.866 149 523 46 187 82 108 115 182 154 114 457 749
2022/20233.974 625 381 250 367 502 521 59 420 645 28 95 81
2023/20241.356 116 282 72 146 113 324 41 50 26 37 19 130
2024/20256.443 178 103 668 217 166 565 407 510 297 348 1.038 1.946
2025/202611.465 1.805 565 812 1.441 1.357 663 1.517 410 1.257 1.203 435 0
Totale 40.164